Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Psychemedics (PMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 104,122
  • Shares Outstanding, K 5,460
  • Annual Sales, $ 38,980 K
  • Annual Income, $ 6,680 K
  • 36-Month Beta 0.90
  • Price/Sales 2.66
  • Price/Cash Flow 11.55
  • Price/Book 6.64

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.78 +1.54%
on 04/28/17
21.16 -9.88%
on 04/26/17
-0.64 (-3.25%)
since 03/28/17
3-Month
13.81 +38.09%
on 01/31/17
26.19 -27.19%
on 01/30/17
-7.39 (-27.93%)
since 01/27/17
52-Week
10.81 +76.41%
on 05/17/16
27.45 -30.53%
on 01/27/17
+4.43 (+30.26%)
since 04/28/16

Most Recent Stories

More News
Psychemedics Corporation Announces Record Q1 Revenues And Earnings

Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2017. The Company also announced a quarterly dividend of $0.15 per share payable to...

PMD : 19.07 (+0.53%)
DEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / April 3, 2017 / Khang & Khang LLP (the "Firm") announces a class action lawsuit against Psychemedics Corporation ("Psychemedics" or the "Company") (Nasdaq: PMD). Investors who...

PMD : 19.07 (+0.53%)
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017

NEW YORK, NY / ACCESSWIRE / April 3, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Psychemedics Corporation ("Psychemedics" or the "Company")...

PMD : 19.07 (+0.53%)
MONDAY DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 31, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Psychemedics Corporation ("Psychemedics" or the "Company") (NASDAQ: PMD)...

PMD : 19.07 (+0.53%)
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation -- Sets Lead Plaintiff Deadline of April 3, 2017 -- PMD

NEW YORK, NY / ACCESSWIRE / March 31, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

PMD : 19.07 (+0.53%)
April 3 Deadline Alert: Law Offices of Howard G. Smith Reminds Psychemedics Corporation Investors of Upcoming Lead Plaintiff Deadline

Law Offices of Howard G. Smith reminds investors of the upcoming April 3, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Psychemedics...

PMD : 19.07 (+0.53%)
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Investors in Psychemedics Corporation of Imminent Lead Plaintiff Deadline

NEW YORK, NY / ACCESSWIRE / March 29, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Psychemedics Corporation ("Psychemedics" or the "Company") (NASDAQ: PMD)...

PMD : 19.07 (+0.53%)
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Investors In Psychemedics Corporation Of Imminent Lead Plaintiff Deadline

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Psychemedics Corporation ("Psychemedics" or the "Company") (NASDAQ: PMD) of the April 3, 2017 deadline to seek the role...

PMD : 19.07 (+0.53%)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation

The following statement is being issued by Levi & Korsinsky, LLP:

PMD : 19.07 (+0.53%)
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 20, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Psychemedics Corporation ("Psychemedics" or the "Company") (NASDAQ: PMD)...

PMD : 19.07 (+0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.

See More

Support & Resistance

2nd Resistance Point 19.50
1st Resistance Point 19.29
Last Price 19.07
1st Support Level 18.82
2nd Support Level 18.56

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.